INTRODUCTION: Characterizing transitions of cognitive state, including reversion from mild cognitive impairment (MCI) to normal cognition (NC) and subsequent cognitive stability or deterioration for post‐reversion, has so far remained limited.METHODS: Using a retrospective cohort of subjects with an MCI diagnosis at study entry and at least two follow‐up visits between 2005 and December 2022, we developed a functional multistate model framework to estimate longitudinal patterns of transition probabilities between different cognitive states.RESULTS: The probability of reversion increased from 2% at baseline to a maximum of 8% by year 10 before gradual decline thereafter. For post‐reversion, the probability of progression to MCI rose from 8% to 35.71% at Year 10 and subsequently stabilized.DISCUSSION: The instantaneous risk of MCI progressing was similar to the risk of re‐progression to MCI for post‐reversion. Post‐reversion subjects remained at an increased risk of cognitive deterioration.Highlights: The instantaneous risk of MCI progressing to AD is similar to the risk of re‐progression to MCI for post‐reversion. The FMSM we developed effectively utilizes multiple longitudinal markers to reveal variable transition patterns between different cognitive states. Considering both spatiotemporal dimensions and sparse irregularities from longitudinal neuroimaging and neuropsychological scales, fMLFPCA and MVFPCA help to extract variation patterns, to capture detailed changes characterizing the multidimensional evolution patterns of MCI.
Background: Identifying individuals with mild cognitive impairment (MCI) who are at increased risk of Alzheimer’s Disease (AD) in cognitive screening is important for early diagnosis and prevention of AD. Objective: This study aimed at proposing a screening strategy based on landmark models to provide dynamic predictive probabilities of MCI-to-AD conversion according to longitudinal neurocognitive tests. Methods: Participants were 312 individuals who had MCI at baseline. The longitudinal neurocognitive tests were the Mini-Mental State Examination, Alzheimer Disease Assessment Scale-Cognitive 13 items, Rey Auditory Verbal Learning Test immediate, learning, and forgetting, and Functional Assessment Questionnaire. We constructed three types of landmark models and selected the optimal landmark model to dynamically predict 2-year probabilities of conversion. The dataset was randomly divided into training set and validation set at a ratio of 7:3. Results: The FAQ, RAVLT-immediate, and RAVLT-forgetting were significant longitudinal neurocognitive tests for MCI-to-AD conversion in all three landmark models. We considered Model 3 as the final landmark model (C-index = 0.894, Brier score = 0.040) and selected Model 3c (FAQ and RAVLT-forgetting as neurocognitive tests) as the optimal landmark model (C-index = 0.898, Brier score = 0.027). Conclusion: Our study shows that the optimal landmark model with a combination FAQ and RAVLTforgetting is feasible to identify the risk of MCI-to-AD conversion, which can be implemented in cognitive screening.